Late Stage Development - Integrated Programs

Late Stage Development - Integrated Programs

Products
Late Stage Development - Integrated Programs
Late Stage Development - Integrated Programs

Information

.Accelerating products through to commercial manufacture - Speed the journey from proof-of-concept to commercial launch. The journey from proof-of-concept to commercial launch can be complex. Speed is critical but it shouldn't come at the expense of product quality. Creating patient-centric formulations and scaling up from pilot-scale to commercial manufacturing, we help clients turn promising molecules into successful drug products.
Distribution Areas
OceaniaNorth America (USA, Canada)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied From
United KingdomUnited States
All categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)APIs (Active Pharmaceutical Ingredients)Formulation developmentOther APIsInnovative APIsProductsServices
Main Categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)APIs (Active Pharmaceutical Ingredients)
QUOTIENT SCIENCES LIMITEDQuotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small molecules & peptide drug programs. We cut through silos across a range of drug development capabilities, saving precious time and money in getting drugs to patients. We work with customers in a flexible way by either designing and delivering fully integrated programs at each stage of the development lifecycle, or by providing them support through tailored individual services in Drug Substance Synthesis & Manufacturing, Formula...

Log in

See all the content and easy-to-use features by logging in or registering!